You’ve probably heard that Alzheimer’s involves sticky protein clumps forming in the brain. But here’s what scientists have never been able to do, until now: watch it happen in real time.

A team at Oregon State University, led by chemistry professor Marilyn Rampersad Mackiewicz, has done exactly that. And what they saw could change how we design treatments for one of the most heartbreaking diseases on the planet.

The Hidden Culprit: Copper

One of Alzheimer’s key features is the buildup of a protein called amyloid-beta in the brain. These sticky clumps disrupt communication between brain cells,  eventually leading to cell death. Scientists have known about this for years. What they didn’t know was exactly how the clumps form, step by step.

The OSU team used a specialized measurement technique to track how certain metals,  especially copper,  can trigger the clumping of amyloid-beta proteins second by second, in real time. This live, molecular-level view had never been achieved before.

Tiny Claws to the Rescue

The team didn’t stop at watching. They also tested molecules called chelators, compounds that act like tiny claws, grabbing onto metal ions. One chelator removed metals broadly, without distinguishing between helpful and harmful ones. But another showed a strong preference for selectively binding copper ions, thought to play a key role in Alzheimer’s-related protein buildup.

Here’s the remarkable part: when that copper was captured, the protein clumping didn’t just slow down. In the lab setting, it reversed.

Why This Matters

Many potential Alzheimer’s treatments have failed, partly because of an incomplete understanding of how amyloid-beta aggregation actually occurs. By seeing the process unfold live, and being able to measure exactly when and how it can be interrupted, researchers now have what Mackiewicz calls “a roadmap for creating more effective therapies.”

As she put it: “With the correct targeting, some of the brain damage might be reversible.”

Clinical treatments based on this work remain years away, but the shift this represents is significant. It moves the question from “does something work?” to “how does it work, and when?”  and that’s exactly the kind of precision medicine needs.

Alzheimer’s affects tens of millions of families worldwide. Breakthroughs like this won’t make headlines the way a cure would,  but they’re often the quiet, essential steps that get us there.

Journal article: https://pubs.acs.org/doi/10.1021/acsomega.5c11345

Source: https://news.oregonstate.edu/news/researchers-find-way-watch-reverse-chemical-process-linked-alzheimer%E2%80%99s-disease